Antihypertensive drug therapy and antioxidant enzyme mRNA levels in spontaneously hypertensive (SHR) rats

Comparative Biochemistry and Physiology - B Biochemistry and Molecular Biology

Volumn 122, Issue 1, 1999, Pages 119-126

  Ma, Lin ^a   Johnson, Peter ^a  

^a OHIO UNIVERSITY   (United States)

Author keywords

Antioxidant enzymes; Captopril; Hydralazine; mRNA analysis; Myocardium; SHR rat; Terazosin

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTIOXIDANT; CAPTOPRIL; CAPTOPRIL PLUS HYDROCHLOROTHIAZIDE; COPPER ZINC SUPEROXIDE DISMUTASE; GLUTATHIONE PEROXIDASE; HYDRALAZINE; HYDROCHLOROTHIAZIDE; MESSENGER RNA; TERAZOSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HEART MUSCLE; HUMAN; LIVER; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0032978049     PISSN: 03050491     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-0491(98)10154-2     Document Type: Article

References (38)

1. Ammendola R, Fiore F, Esposito F, Caserta G, Mesuraca M, Russo T, Cimino F. Differentially expressed mRNAs as a consequence of oxidative stress in intact cells. FEBS Lett 1995;371:209-13.
2. Bartosz M, Kedziora J, Bartosz G. Antioxidant and prooxidant properties of captopril and enalapril. Free Rad Biol Med 1997;23:729-35.
3. Cabell KS, Ma L, Johnson P. Effects of antihypertensive drugs on rat tissue antioxidant enzyme activities and lipid peroxidation levels. Biochem Pharmacol 1997;46:133-41.
4. Chen Y, Frank L. Differential gene expression of antioxidant enzymes in the perinatal rat lung. Pediatric Res 1993;34:27-31.
5. Clerch LB, Wright A, Massaro D. Dinucleotide-binding site of bovine liver catalase mimics a catalase mRNA-binding protein domain. Am J Physiol 1996;270:L790-4.
6. Cohen J. Long-term efficacy and safety of terazosin. J Clin Pharmacol 1993;33:272-8.
7. Cowan DB, Weisel RD, Williams WG, Mickle DA. Identification of oxygen response elements in the 5́ flanking region of the human glutathione peroxidase gene. J Biol Chem 1993;268:26904-10.
8. de Cavanagh EMV, Inserra F, Ferder L, Romano L, Ercole L, Fraga CG. Superoxide dismutase and glutathione peroxidase activities are increased by enalapril and captopril in mouse liver. FEBS Lett 1995;361:22-4.
9. Elkayam U. Prevention of nitrate tolerance with concomitant administration of hydralazine. Can J Cardiol 1996;12:17C-21.
10. Engelman RM, Rousou JA, Iyengar J, Das DK. Captopril, an ACE inhibitor for optimizing reperfusion after acute myocardial infarction. Ann Thorac Surg 1991;52:918-26.
11. Guyton KZ, Xu Q, Holbrook NJ. Induction of the mammalian stress response gene GADD153 by oxidative stress: role of AP-1 element. Biochem J 1996;314:547-54.
12. Ho Y-S, Dey MS, Crapo JD. Antioxidant enzyme expression in rat lungs during hyperoxia. Am J Physiol 1996;270:L810-8.
13. Hong H, Johnson P. Antioxidant enzyme activities and lipid peroxidation levels in exercised and hypertensive rat tissues. Int J Biochem Cell Biol 1995;27:923-31.
14. Jaiswal AK. Antioxidant response element. Biochem Pharmacol 1994;48:439-44.
15. Kirshenbaum LA, Singal PK Increase in endogenous antioxidant enzymes protects hearts against reperfusion injury. Am J Physiol 1993;265:H484-93.
16. Kubisch HM, Wang J, Bray TM, Phillips JP. Targeted overexpression of Cu/Zn Superoxide dismutase protects pancreatic beta-cells against oxidative stress. Diabetes 1997;46:1563-6.
17. Lai CC, Peng M, Huang L, Huang WH, Chiu TH. Chronic exposure of neonatal cardiac myocytes to hydrogen peroxide enhances the expression of catalase. J Mol Cell Cardiol 1996;28:1157-63.
18. Lapenna D, Cuccurullo F. Captopril: does it act as a direct antioxidant by free radical scavenging in humans? Free Radic Biol Med 1995;18:377-8.
19. Lee JJ, Costlow NA. A molecular titration assay to measure transcript prevalence levels. Methods Enzymol 1987;152:633-49.
20. Lemke LE, McQueen CA. Acetylation and its role in the mutagenicity of the antihypertensive agent hydralazine. Drug Metab Dispos 1995;23:559-65.
21. Noda Y, Mori A, Packer L. Free radical scavenging properties of alacepril metabolites and lisinopril. Res Commun Mol Pathol Pharmacol 1997;96:125-36.
22. Oh-ishi S, Kizaki T, Nagasawa J, Izawa T, Kombayashi T, Nagata N, Suzuki K, Taniguchi N, Ohno H. Effects of endurance training on Superoxide dismutase activity, content and mRNA expression in rat muscle. Clin Exp Pharmacol Physiol 1997;24:326-32.
23. O'Prey J, Ramsay S, Chambers I, Harrison PR. Transcriptional up-regulation of the mouse cytosolic glutathione peroxidase gene in erythroid cells is due to a tissue-specific 3́ enhancer containing functionally important CACC/GT motifs and binding sites for GATA and Ets transcription factors. Mol Cell Biol 1993;13:6290-303.
24. Qian ZM, Xu MF, Tang PL. Superoxide dismutase does protect the cultured rat cardiac myocytes against hypoxia/reoxygenation injury. Free Radic Res 1997;27:13-21.
25. Rahman I, Clerch LB, Massaro D. Rat lung antioxidant enzyme induction by ozone. Am J Physiol 1991;260:L412-8.
26. Rezkalla SH, Raikar S, Kloner RA. Treatment of viral myocarditis with focus on captopril. Am J Cardiol 1996;77:634-7.
27. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning. A Laboratory Manual. 2nd edn. Plain View, NY: Cold Spring Harbor Laboratory Press, 1989.
28. Sato K, Ito K, Kohara H, Yamaguchi Y, Adachi K, Endo H. Negative regulation of catalase gene expression in hepatoma cells. Mol Cell Biol 1992;12:2525-33.
29. Schneider R, Iscovitz H, Ilan Z, Bernstein K, Gros M, Iaina A. Oxygen free radical scavenger system intermediates in essential hypertensive patients before and immediately after sublingual captopril administration. Isr J Med Sci 1990;26:491-5.
30. Seo SJ, Kim HT, Cho G, Rho HM, Jung G. Sp1 and C/EBP-related factor regulate the transcription of human Cu/Zn SOD gene. Gene 1996;178:177-85.
31. Sen CK, Packer L. Antioxidant and redox regulation of gene transcription. FASEB J 1996;10:709-20.
32. Sogaard P, Klausen IC, Rungby J, Faergeman O, Thygesen K. Lipoprotein(a) and oxygen free radicals in survivors of acute myocardial infarction: Effects of captopril. Cardiology 1996;87:18-22.
33. Suzuki H, DeLano FA, Parks DA, Jamshidi N, Granger DN, Ishi H, Suematsu M, Zweifach BW, Schmid-Schonbein GW. Xanthine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats. Proc Natl Acad Sci USA 1998;95:4754-9.
34. Takeda N, Tanamura A, Iwai T, Kato M, Noma K, Nagano M. Beneficial effect of ACE inhibitor in congestive heart failure. Mol Cell Biochem 1993;129:139-43.
35. Tang Z, Shou I, Wang LN, Fukui M, Tomino Y. Effects of antihypertensive drugs or glycemic control on antioxidant enzyme activities in spontaneously hypertensive rats with diabetes. Nephron 1997;76:323-30.
36. Tomanek RJ, Trout JJ, Lauva IK. Cytochemistry of myocardial structures related to degenerative processes in spontaneously hypertensive and normotensive rats. J Mol Cell Cardiol 1984;16:227-37.
37. Vulpis V, Roncali L, Bertossi M, Nico B, Seccia T, Ticci S, Pirelli A. Left-ventricular hypertrophy in the spontaneously hypertensive rat: effect of ACE inhibitors on ultrastructural morphology. Cardiology 1994;84:14-24.
38. Weglarz L, Bartosz G. Hydralazine stimulates production of oxygen free radicals in Eagle's medium and cultured fibroblasts. Free Radic Biol Med 1991;11:149-55.